# Efficacy of Treatment With Pramipexole or Risperidone in Patients With Refractory Obsessive-compulsive Disorder (OCD)

> **NCT05401019** · PHASE2 · WITHDRAWN · sponsor: **Clinical Academic Center (2CA-Braga)**

## Conditions studied

- Obsessive-Compulsive Disorder

## Interventions

- **DRUG:** Pramipexole
- **DRUG:** Risperidone

## Key facts

- **NCT ID:** NCT05401019
- **Lead sponsor:** Clinical Academic Center (2CA-Braga)
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2022-06
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** This clinical trial was not approved by the regulatory entities. It was reviewed and a new trial was re-submitted.
- **Last updated:** 2024-09-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05401019

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05401019, "Efficacy of Treatment With Pramipexole or Risperidone in Patients With Refractory Obsessive-compulsive Disorder (OCD)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT05401019. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*